Company Number: 14719215

Analysis Date: 2025-07-29 19:53 UTC

Financial Health Assessment for PHARMEDICAL LTD

---

1. Financial Health Score: B

Explanation:
PHARMEDICAL LTD shows strong improvement from its initial year of operation to the current financial year. The company has moved from a negative net asset position (£-400) to a solid positive net asset base (£78,141), reflecting healthy growth in working capital and shareholder funds. However, as a micro-entity still in its infancy with limited operational history and a single employee, there remain risks related to scale, cash flow consistency, and dependency on key individuals. Hence, a grade of B indicates generally good financial health with room for cautious monitoring and improvement.

---

2. Key Vital Signs

Metric	2023 (Initial)	2024 (Latest)	Interpretation
Current Assets	£8	£107,499	Significant increase in liquid and receivable assets—indicative of cash injections or receivables balance.
Current Liabilities	£408	£29,358	Increase in short-term obligations but manageable relative to assets.
Net Current Assets	(£400)	£78,141	Strong positive working capital; "healthy cash flow buffer" to meet short-term debts.
Net Assets / Equity	(£400)	£78,141	Transition from negative to positive net worth, indicating improved solvency and owner investment.
Employees	1	1	Stable staffing; small scale operation.
Director’s Loan	N/A	£6,264 owed to director	Director has financially supported the company, showing commitment but with potential liquidity risk if not repaid timely.

---

3. Diagnosis

• Positive Signs (Healthy Vital Signs):

  • The company has successfully built a net asset base of over £78k within approximately 1.5 years of operation, a "strong pulse" reflecting good capital influx or retained earnings.
  • Working capital is robust, with current assets nearly 3.7 times current liabilities, indicating good short-term liquidity and ability to pay bills on time.
  • The sole director and significant shareholder is actively involved and has contributed funds personally, showing "strong caregiver involvement" in the business.

• Symptoms of Concern:

  • The company remains very small with only one employee (the director), which adds operational risk due to limited human resource capacity and potential over-reliance on a single individual.
  • Increase in current liabilities from £408 to £29,358 suggests growth but also rising obligations that must be managed to avoid cash flow "stress".
  • Director's loan of £6,264 is a liability that could pressure liquidity if repayment is delayed or cash inflows fluctuate.

• Contextual Notes:

  • As a micro-entity, PHARMEDICAL LTD benefits from simplified reporting but this limits visibility on profitability, as no profit and loss account has been filed.
  • The sector (general medical practice activities) can have stable demand but requires compliance and regulatory diligence.

---

4. Recommendations

1. Maintain Cash Flow Vigilance:
   Regularly monitor and forecast cash flows to ensure current liabilities do not outpace liquid assets, preventing potential "circulatory blockages" in cash availability.

2. Reduce Director Loan Exposure:
   Plan to either repay or formalize the director’s loan arrangement to avoid personal financial risk and clarify company indebtedness.

3. Plan for Scaling and Staffing:
   Consider strategies for hiring or outsourcing to mitigate risks from single-person dependency—like a "backup system" in medical practice operations.

4. Prepare for Next Financial Year Reporting:
   Even as a micro-entity, consider preparing at least a summary profit and loss internally to track operational performance and identify profitability trends early.

5. Compliance and Governance:
   Ensure ongoing compliance with filing deadlines and regulatory requirements to avoid penalties and maintain corporate health.

---